Detalhe da pesquisa
1.
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.
Intern Med J
; 54(2): 328-336, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146232
2.
Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Intern Med J
; 53(4): 599-609, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441109
3.
Chimeric antigen receptor T-cell therapy.
Aust Prescr
; 46(2): 36-39, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-38053567
4.
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.
Intern Med J
; 50(6): 667-679, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415723
5.
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction.
Eur J Haematol
; 107(4): 497-499, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129711
6.
Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma.
Front Immunol
; 12: 620596, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33708212
7.
Mass Cytometry Discovers Two Discrete Subsets of CD39-Treg Which Discriminate MGUS From Multiple Myeloma.
Front Immunol
; 10: 1596, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31428081
8.
Quality of life related to oral versus subcutaneous iron chelation: a time trade-off study.
Value Health
; 10(6): 451-6, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17970927
9.
Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: a subanalysis of the EPIC study of deferasirox.
Int J Hematol
; 93(3): 319-328, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21374076
10.
Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma.
Leuk Lymphoma
; 50(11): 1860-4, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19883313